Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Return on Equity (2021 - 2025)

Historic Return on Equity for Roivant Sciences (ROIV) over the last 5 years, with Q3 2025 value amounting to 0.07%.

  • Roivant Sciences' Return on Equity rose 700.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.07% for FY2025, which is 1200.0% up from last year.
  • Roivant Sciences' Return on Equity amounted to 0.07% in Q3 2025, which was up 700.0% from 0.06% recorded in Q2 2025.
  • In the past 5 years, Roivant Sciences' Return on Equity ranged from a high of 0.07% in Q1 2025 and a low of 0.72% during Q4 2022
  • Its 5-year average for Return on Equity is 0.27%, with a median of 0.24% in 2021.
  • As far as peak fluctuations go, Roivant Sciences' Return on Equity plummeted by -4500bps in 2022, and later surged by 6900bps in 2024.
  • Over the past 5 years, Roivant Sciences' Return on Equity (Quarter) stood at 0.27% in 2021, then crashed by -165bps to 0.72% in 2022, then skyrocketed by 83bps to 0.12% in 2023, then surged by 156bps to 0.07% in 2024, then grew by 1bps to 0.07% in 2025.
  • Its Return on Equity stands at 0.07% for Q3 2025, versus 0.06% for Q2 2025 and 0.07% for Q1 2025.